AngioDynamics Class II Catheter Recall - Guidewire Passage Defect
Summary
FDA Class II recall initiated March 3, 2026 for AngioDynamics Soft-Vu Angiographic Catheters due to a manufacturing defect that may prevent the appropriately sized guidewire from passing through the catheter hub inner diameter. The recalling firm distributed 4,925 units (985 boxes) worldwide, including US nationwide and 25 countries. Customers are instructed to immediately stop using affected devices, remove them from inventory, and return products to AngioDynamics.
What changed
FDA classified a Class II recall for AngioDynamics Soft-Vu Angiographic Catheters after identifying that affected devices contain a manufacturing defect (nonconforming material/component) which may prevent appropriately sized guidewires from passing through the catheter hub inner diameter.
Healthcare facilities that have purchased or distributed these catheters should immediately cease use, segregate affected inventory by lot number (A2825033, A2825034, A2825132, A2825133, A3725048, A3725049), and initiate return procedures per AngioDynamics instructions. Facilities are also required to notify all downstream users and clinics that received the product.
What to do next
- Stop using the devices subject to this recall and share the notification to all users of the devices within your facility immediately
- Remove any affected items/lots from your inventory
- Package and Return the Recalled Product
Archived snapshot
Apr 20, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Class 2 Device Recall Angiodynamics SoftVu
- Databases
| 510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards |
| CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | |
| New Search | ) |
| | Class 2 Device Recall Angiodynamics SoftVu | |
| Date Initiated by Firm | March 03, 2026 |
|---|---|
| Date Posted | April 17, 2026 |
| Recall Status | Open , Classified |
| Recall Number | Z-1862-2026 |
| Recall Event ID | 98463 |
| 510(K)Number | K112452 K161596 K173762 |
| Product Classification | Catheter, intravascular, diagnostic - Product Code DQO |
| Product | Soft-Vu Angiographic Catheter, Kumpe, Non-Braided; |
SOFT-VU KMP 4F X 65CM 038 NB 0SH;
Catalog No.: 10714014;
Product/UPN No.: H787107140145 (Box), H787107140140 (Pouch);
Box Quantity: 5 pouches; |
| Code Information | SOFT-VU KMP 4F X 65CM 038 NB 0SH;
Catalog No.: 10714014;
Product/UPN No.: H787107140145 (Box), H787107140140 (Pouch);
UDI-DI: 25051684007891(Box), 15051684007894(Pouch);
Lot No.: A2825033, A2825034, A2825132, A2825133, A3725048, A3725049; |
| FEI Number | 1319211 |
| Recalling Firm/
Manufacturer | Angiodynamics, Inc.
603 Queensbury Ave
Queensbury NY 12804-7619 |
| For Additional Information Contact | Kasey Newcomb
978-333-1108 |
| Manufacturer Reason
for Recall | The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub. |
| FDA Determined
Cause | Nonconforming Material/Component |
| Action | On March 3, 2026 URGENT VOLUNTARY MEDICAL DEVICE RECALL letters were sent to customers.
Actions to be taken:
IMMEDIATELY:
1. Stop using the devices subject to this recall and share the notification to all users of the deviceswithin your facility immediately.
2. Provide a copy of this recall notification to all sites or clinics to which you have distributed affectedproduct.
3. Remove any affected items/lots from your inventory (whether in labs, Central Supply, Shipping andReceiving or ANY other location).
4. Segregate this product in a secure location for return to AngioDynamics, Inc.
5. Package and Return the Recalled Product. |
| Quantity in Commerce | 4925 units (985 boxes) |
| Distribution | Worldwide distribution - US Nationwide and the countries of Austria, Australia, Belgium, Canada, China, Chile, Curacao, Czech Republic, Germany, Ireland, Israel, Italy, Lebanon, Netherlands, New Zealand, Panama, Slovenia, South Africa, Spain, Sweden, Thailand. |
| Total Product Life Cycle | TPLC Device Report |
| 1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes. | |
| 510(K) Database | 510(K)s with Product Code = DQO |
Parties
Related changes
Get daily alerts for FDA Device Recalls (Class II)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when FDA Device Recalls (Class II) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.